1.
Total Health | Oncology 📖🔬
@TotalHealthConf
T-DXd in HER2-low #esophagogastriccancer
@JCO_ASCO
doi.org/10.1200/JCO.22…
phs-II, 45 pts; C1 IHC 2+ vs C1+
O… twitter.com/i/web/status/1…
@JCO_ASCO
doi.org/10.1200/JCO.22…
phs-II, 45 pts; C1 IHC 2+ vs C1+
O… twitter.com/i/web/status/1…
Retweet of status by @ArndtVogel
01 Feb 23
copy & paste +upvote -downvote 🔥T-DXd in HER2-low #esophagogastriccancer
@JCO_ASCO
https://t.co/92F6dcQ6fO
✅🇯🇵phs-II, 45 pts; C1 IHC 2+ vs C1+
👉O… https://t.co/G291PQU3VG
2.
Total Health | Oncology 📖🔬
@TotalHealthConf
Can’t wait to share all the incredible info about to be shared!! Set your ! #bcsm #breastcancer twitter.com/totalhealthcon…
Retweet of status by @drteplinsky
17 Jan 23
copy & paste +upvote -downvote Can’t wait to share all the incredible info about to be shared!! Set your ⏰! #bcsm #breastcancer https://t.co/GF9vOM1Fqa
3.
4.
5.
6.
7.
Total Health | Oncology 📖🔬
@TotalHealthConf
#HER2DX looks at tumor size, nodal status, and 4 gene expression signatures relating to immune infiltration, proli… twitter.com/i/web/status/1…
09 Dec 22
copy & paste +upvote -downvote 🎯#HER2DX looks at tumor size, nodal status, and 4 gene expression signatures relating to immune infiltration, proli… https://t.co/ybWTxgnJxJ
Total Health | Oncology 📖🔬
@TotalHealthConf
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
now published in @NEJMEvidence… twitter.com/i/web/status/1…
now published in @NEJMEvidence… twitter.com/i/web/status/1…
Retweet of status by @ArndtVogel
23 Aug 22
copy & paste +upvote -downvote 🔥Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer🔥
📢now published in @NEJMEvidence… https://t.co/J1pVltm1a9
Total Health | Oncology 📖🔬
@TotalHealthConf
News from ADAPT-TN: in a population of mostly stage II TNBC, 12wks of abraxane-gem or -carbo achieved 35% pCR ra… twitter.com/i/web/status/1…
Retweet of status by @PTarantinoMD
01 Aug 22
copy & paste +upvote -downvote News from 🇩🇪 ADAPT-TN: in a population of mostly stage II TNBC, 12wks of abraxane-gem or -carbo achieved 35% pCR ra… https://t.co/OSnkgWiC4l
Total Health | Oncology 📖🔬
@TotalHealthConf
Critical to closing the global pain divide is recognizing #PalliativeCare as a medical specialty at the national… twitter.com/i/web/status/1…
Retweet of status by @BRosa_PhD
26 May 22
copy & paste +upvote -downvote ‼️Critical to closing the global pain divide is recognizing #PalliativeCare as a medical specialty at the national… https://t.co/ANy0TBqXbH
Total Health | Oncology 📖🔬
@TotalHealthConf
Our @ASCO Ed book chapter out now #ASCO22 @AnnPartridgeMD
"Special consideration of the unique medical and li… twitter.com/i/web/status/1…
"Special consideration of the unique medical and li… twitter.com/i/web/status/1…
Retweet of status by @MeganTesch
19 May 22
copy & paste +upvote -downvote 📕 Our @ASCO Ed book chapter out now ‼️ #ASCO22 @AnnPartridgeMD
"Special consideration of the unique medical and li… https://t.co/MNetJA2ZjG
8.
9.
10.
11.
Total Health | Oncology 📖🔬
@TotalHealthConf
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
16 May 22
copy & paste +upvote -downvote ⭐️🎯🧬FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients… https://t.co/cxPiHjtxRx
Total Health | Oncology 📖🔬
@TotalHealthConf
See how the same tumor looks with 2 different imaging studies.
FDG PET vs sodium fluoride (NaF) PET of osteosar… twitter.com/i/web/status/1…
FDG PET vs sodium fluoride (NaF) PET of osteosar… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
28 Apr 22
copy & paste +upvote -downvote ⭐️See how the same tumor looks with 2 different imaging studies.
✅FDG PET vs sodium fluoride (NaF) PET of osteosar… https://t.co/vEQN550YwC
Total Health | Oncology 📖🔬
@TotalHealthConf
OS curves for neoadjuvant (, #CM816) or adjuvant (, #KN091) administration of PD1-blockade in resectable NSCLC.… twitter.com/i/web/status/1…
Retweet of status by @PTarantinoMD
11 Apr 22
copy & paste +upvote -downvote OS curves for neoadjuvant (⬆️, #CM816) or adjuvant (⬇️, #KN091) administration of PD1-blockade in resectable NSCLC.… https://t.co/XzB2uakTAh
Total Health | Oncology 📖 🔬
@TotalHealthConf
We're all guilty of putting self care on hold during COVID but breast cancer screenings shouldn't be one of them… twitter.com/i/web/status/1…
Retweet of status by @TGHCancer_Nurse
05 Oct 21
copy & paste +upvote -downvote We're all guilty of putting self care on hold during COVID but breast cancer screenings shouldn't be one of them💕… https://t.co/R22dsRxx2w
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13
copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊